no help available
no help available
userThe blue social bookmark and publication sharing system.
actions for all displayed bookmarks:
export:
sort:
- criterion: date, title
- order: ascending, descending
others:
- display: all, bookmarks only
- bookmarks per page: 5 10 20 50 100
bookmarks
actions for all displayed publications:
export:
sort:
- criterion: date, title
- order: ascending, descending
- advanced...
others:
- display: all, publications only
- publications per page: 5 10 20 50 100
publications (33)
- browse
- Angiogenesis as tag from all users
- related tags
- concepts
- tags
- Humans
- Research
- Growth
- Endothelial
- Factor
- Vascular
- protein
- blood
- Neoplasms
- metabolism
- methods
- Animals
- cells
- Human
- therapy
- pathology
- &
- A
- drug
- Tyrosine
- Cell
- analysis
- Cells
- Factors
- Proteins
- Neovascularization
- Biological
- response
- genetics
- Antibodies
- physiology
- Tumor
- Female
- Kinase
- Pathologic
- effects
- pharmacology
- use
- Kinases
- Laboratories
- Inhibitors
- Receptors
- Blood
- therapeutic
- Receptor
- Male
- inhibitors
- Chemistry
- antagonists
- Protein-Tyrosine
- No matching items.
- D. Fukumura, and R. K. Jain. Microvasc.Res. 74(2-3):72-84 (2007)D. Fukumura, and R. K. Jain. Microvasc.Res. 74(2-3):72-84 (2007)3 years and 4 months agoby kanefendt1
- S. E. Deprimo, and C. Bello. Ann.Oncol (2007)S. E. Deprimo, and C. Bello. Ann.Oncol (2007)3 years and 4 months agoby kanefendt1
- F. Bertolini, P. Mancuso, Y. Shaked, and R. S. Kerbel. Drug Discov.Today 12(19-20):806-812 (2007)F. Bertolini, P. Mancuso, Y. Shaked, and R. S. Kerbel. Drug Discov.Today 12(19-20):806-812 (2007)3 years and 4 months agoby kanefendt1
- E. Chorianopoulos, D. Jager, H. A. Katus, and N. Frey. Clin.Res.Cardiol. 96(11):829-830 (2007)E. Chorianopoulos, D. Jager, H. A. Katus, and N. Frey. Clin.Res.Cardiol. 96(11):829-830 (2007)3 years and 4 months agoby kanefendt1
- &
- Aged
- Agents
- Angiogenesis
- Antineoplastic
- Carcinoma
- Cardiomyopathies
- Cell
- Dysfunction
- Echocardiography
- Female
- Humans
- Illness
- Index
- Indoles
- Inhibitors
- Kidney
- Kinase
- Kinases
- Left
- Neoplasms
- Protein-Tyrosine
- Pyrroles
- Renal
- Severity
- Tyrosine
- Ventricular
- adverse
- antagonists
- chemically
- contraindications
- drug
- effects
- induced
- inhibitors
- of
- therapy
& Aged Agents Angiogenesis Antineoplastic Carcinoma Cardiomyopathies Cell Dysfunction Echocardiography Female Humans Illness Index Indoles Inhibitors Kidney Kinase Kinases Left Neoplasms Protein-Tyrosine Pyrroles Renal Severity Tyrosine Ventricular adverse antagonists chemically contraindications drug effects induced inhibitors of therapy - J. Folkman. Nat.Rev.Drug Discov. 6(4):273-286 (2007)J. Folkman. Nat.Rev.Drug Discov. 6(4):273-286 (2007)3 years and 4 months agoby kanefendt1
- J. M. Ebos, C. R. Lee, J. G. Christensen, A. J. Mutsaers, and R. S. Kerbel. Proc.Natl.Acad.Sci.U.S.A 104(43):17069-17074 (2007)J. M. Ebos, C. R. Lee, J. G. Christensen, A. J. Mutsaers, and R. S. Kerbel. Proc.Natl.Acad.Sci.U.S.A 104(43):17069-17074 (2007)3 years and 4 months agoby kanefendt1
- &
- A
- Administration
- Agents
- Angiogenesis
- Animals
- Antineoplastic
- Antitumor
- Assays
- Blood
- Cell
- Dose-Response
- Drug
- Endothelial
- Factor
- Female
- Growth
- Humans
- Hypoxia
- Indoles
- Inducing
- Line
- Mice
- Model
- Neoplasms
- Organ
- Outcome
- Placenta
- Pregnancy
- Proteins
- Pyrroles
- RANGE
- Receptor-2
- Relationship
- Research
- Schedule
- Scid
- Specificity
- Treatment
- Tumor
- Tyrosine
- Vascular
- Xenograft
- administration
- blood
- dosage
- drug
- effects
- metabolism
- pathology
- pharmacology
- protein
- response
- therapy
- toxicity
& A Administration Agents Angiogenesis Animals Antineoplastic Antitumor Assays Blood Cell Dose-Response Drug Endothelial Factor Female Growth Humans Hypoxia Indoles Inducing Line Mice Model Neoplasms Organ Outcome Placenta Pregnancy Proteins Pyrroles RANGE Receptor-2 Relationship Research Schedule Scid Specificity Treatment Tumor Tyrosine Vascular Xenograft administration blood dosage drug effects metabolism pathology pharmacology protein response therapy toxicity - S. Faivre, G. Demetri, W. Sargent, and E. Raymond. Nat.Rev.Drug Discov. 6(9):734-745 (2007)S. Faivre, G. Demetri, W. Sargent, and E. Raymond. Nat.Rev.Drug Discov. 6(9):734-745 (2007)3 years and 4 months agoby kanefendt1
- &
- A
- Angiogenesis
- Animals
- Carcinoma
- Clinical
- Design
- Drug
- Endothelial
- Factor
- France
- Growth
- Humans
- Indoles
- Inhibitors
- Kinase
- Kinases
- Neoplasm
- Neoplasms
- Protein-Tyrosine
- Pyrroles
- Receptors
- Resistance
- Topic
- Trials
- Tyrosine
- Vascular
- adverse
- antagonists
- as
- biosynthesis
- blood
- drug
- effects
- enzymology
- inhibitors
- metabolism
- pharmacology
- response
- supply
- therapeutic
- therapy
- use
& A Angiogenesis Animals Carcinoma Clinical Design Drug Endothelial Factor France Growth Humans Indoles Inhibitors Kinase Kinases Neoplasm Neoplasms Protein-Tyrosine Pyrroles Receptors Resistance Topic Trials Tyrosine Vascular adverse antagonists as biosynthesis blood drug effects enzymology inhibitors metabolism pharmacology response supply therapeutic therapy use - J. Harper, and M. A. Moses. EXS (2006)J. Harper, and M. A. Moses. EXS (2006)3 years and 4 months agoby kanefendt1
- F. A. Eskens, and J. Verweij. Eur.J.Cancer 42(18):3127-3139 (2006)F. A. Eskens, and J. Verweij. Eur.J.Cancer 42(18):3127-3139 (2006)3 years and 4 months agoby kanefendt1
- &
- A
- Angiogenesis
- Antibodies
- Endothelial
- Factor
- Growth
- Humans
- Inhibitors
- Kinase
- Kinases
- Medical
- Monoclonal
- Neoplasms
- Neovascularization
- Oncology
- Pathologic
- Protein
- Protein-Tyrosine
- Receptors
- Tyrosine
- Vascular
- adverse
- antagonists
- blood
- control
- drug
- effects
- inhibitors
- prevention
- protein
- supply
- therapy
- toxicity
& A Angiogenesis Antibodies Endothelial Factor Growth Humans Inhibitors Kinase Kinases Medical Monoclonal Neoplasms Neovascularization Oncology Pathologic Protein Protein-Tyrosine Receptors Tyrosine Vascular adverse antagonists blood control drug effects inhibitors prevention protein supply therapy toxicity - A. Morabito, Maio E. De, Maio M. Di, N. Normanno, and F. Perrone. Oncologist. 11(7):753-764 (2006)A. Morabito, Maio E. De, Maio M. Di, N. Normanno, and F. Perrone. Oncologist. 11(7):753-764 (2006)3 years and 4 months agoby kanefendt1
- A. O. Rehman, and C. Y. Wang. Trends Cell Biol. 16(6):293-300 (2006)A. O. Rehman, and C. Y. Wang. Trends Cell Biol. 16(6):293-300 (2006)3 years and 4 months agoby kanefendt1
- &
- Agents
- Angiogenesis
- Animals
- Binding
- Biological
- Blood
- Carcinogens
- Cells
- Endothelial
- Genes
- Humans
- Inducing
- Inhibitors
- Laboratories
- Ligands
- Models
- Neoplasms
- Neovascularization
- Notch
- Pathologic
- Receptors
- Signal
- Suppressor
- Transduction
- Tumor
- Vessels
- blood
- cells
- development
- growth
- metabolism
- physiology
- supply
- therapy
& Agents Angiogenesis Animals Binding Biological Blood Carcinogens Cells Endothelial Genes Humans Inducing Inhibitors Laboratories Ligands Models Neoplasms Neovascularization Notch Pathologic Receptors Signal Suppressor Transduction Tumor Vessels blood cells development growth metabolism physiology supply therapy - H. M. Verheul, and H. M. Pinedo. Nat.Rev.Cancer 7(6):475-485 (2007)H. M. Verheul, and H. M. Pinedo. Nat.Rev.Cancer 7(6):475-485 (2007)3 years and 4 months agoby kanefendt1
- &
- A
- Administration
- Agents
- Angiogenesis
- Antineoplastic
- Biological
- Blood
- Clinical
- Coagulation
- Drug
- Endothelial
- Factor
- Function
- Growth
- Humans
- Hypertension
- Inhibitors
- Left
- Models
- Neoplasm
- Platelets
- Research
- Resistance
- Schedule
- Signal
- Thrombosis
- Topic
- Transduction
- Trials
- Vascular
- Ventricular
- administration
- adverse
- antagonists
- as
- chemically
- dosage
- drug
- effects
- etiology
- induced
- inhibitors
- physiology
- toxicity
& A Administration Agents Angiogenesis Antineoplastic Biological Blood Clinical Coagulation Drug Endothelial Factor Function Growth Humans Hypertension Inhibitors Left Models Neoplasm Platelets Research Resistance Schedule Signal Thrombosis Topic Transduction Trials Vascular Ventricular administration adverse antagonists as chemically dosage drug effects etiology induced inhibitors physiology toxicity - A. P. Brown, D. E. Citrin, and K. A. Camphausen. Cancer Metastasis Rev. 27(3):415-434 (2008)A. P. Brown, D. E. Citrin, and K. A. Camphausen. Cancer Metastasis Rev. 27(3):415-434 (2008)3 years and 4 months agoby kanefendt1
- V. Brower. J.Natl.Cancer Inst. 101(12):846-847 (2009)V. Brower. J.Natl.Cancer Inst. 101(12):846-847 (2009)3 years and 4 months agoby kanefendt1
- A
- Analysis
- Angiogenesis
- Animals
- Antibodies
- Benzenesulfonates
- Biological
- Cells
- Cytokines
- Disease-Free
- Endothelial
- Factor
- Growth
- Humans
- Indoles
- Inhibitors
- Markers
- Monoclonal
- Neoplasms
- Pyridines
- Pyrroles
- Survival
- Tumor
- Vascular
- blood
- drug
- effects
- metabolism
- mortality
- pathology
- pharmacology
- response
- supply
- therapeutic
- therapy
- use
A Analysis Angiogenesis Animals Antibodies Benzenesulfonates Biological Cells Cytokines Disease-Free Endothelial Factor Growth Humans Indoles Inhibitors Markers Monoclonal Neoplasms Pyridines Pyrroles Survival Tumor Vascular blood drug effects metabolism mortality pathology pharmacology response supply therapeutic therapy use - F. A. Eskens, N. Steeghs, J. Verweij, J. L. Bloem, O. Christensen, Doorn L. van, J. Ouwerkerk, M. J. Jonge, J. W. Nortier, J. Kraetzschmar, P. Rajagopalan, and H. Gelderblom. J.Clin.Oncol. 27(25):4169-4176 (2009)F. A. Eskens, N. Steeghs, J. Verweij, J. L. Bloem, O. Christensen, Doorn L. van, J. Ouwerkerk, M. J. Jonge, J. W. Nortier, J. Kraetzschmar, P. Rajagopalan, and H. Gelderblom. J.Clin.Oncol. 27(25):4169-4176 (2009)3 years and 4 months agoby kanefendt1
- &
- A
- Administration
- Adolescent
- Adult
- Aged
- Angiogenesis
- Biological
- Contrast
- Dose
- Dose-Response
- Drug
- Endothelial
- Factor
- Factors
- Fatigue
- Female
- Growth
- Human
- Humans
- Hypertension
- Imaging
- Inhibitors
- Kinase
- Magnetic
- Male
- Markers
- Maximum
- Media
- Medical
- Metastasis
- Middle
- Neoplasm
- Neoplasms
- Oncology
- Oral
- Outcome
- Pharmacokinetics
- Plasma
- Platelet-Derived
- Protein
- Proteins
- Proto-Oncogene
- Pyridazines
- Pyridines
- Receptor
- Receptor-2
- Receptor-3
- Relationship
- Research
- Resonance
- Safety
- Schedule
- Time
- Tolerated
- Treatment
- Tumor
- Tyrosine
- Vascular
- Young
- administration
- adverse
- antagonists
- beta
- blood
- c-kit
- diagnostic
- dosage
- drug
- effects
- enzymology
- inhibitors
- methods
- pathology
- protein
- response
- supply
- therapy
- toxicity
- use
& A Administration Adolescent Adult Aged Angiogenesis Biological Contrast Dose Dose-Response Drug Endothelial Factor Factors Fatigue Female Growth Human Humans Hypertension Imaging Inhibitors Kinase Magnetic Male Markers Maximum Media Medical Metastasis Middle Neoplasm Neoplasms Oncology Oral Outcome Pharmacokinetics Plasma Platelet-Derived Protein Proteins Proto-Oncogene Pyridazines Pyridines Receptor Receptor-2 Receptor-3 Relationship Research Resonance Safety Schedule Time Tolerated Treatment Tumor Tyrosine Vascular Young administration adverse antagonists beta blood c-kit diagnostic dosage drug effects enzymology inhibitors methods pathology protein response supply therapy toxicity use - V. Brower. J.Natl.Cancer Inst. 101(11):780-781 (2009)V. Brower. J.Natl.Cancer Inst. 101(11):780-781 (2009)3 years and 4 months agoby kanefendt1
- &
- Administration
- Analysis
- Angiogenesis
- Antibodies
- Antineoplastic
- Biological
- Chemotherapy
- Colorectal
- Combined
- Controlled
- Drug
- Humans
- Inhibitors
- Markers
- Monoclonal
- Neoplasms
- Pericytes
- Protocols
- Randomized
- Research
- Schedule
- Survival
- Topic
- Trials
- Tumor
- administration
- analysis
- as
- blood
- dosage
- drug
- effects
- mortality
- supply
- therapeutic
- therapy
- use
& Administration Analysis Angiogenesis Antibodies Antineoplastic Biological Chemotherapy Colorectal Combined Controlled Drug Humans Inhibitors Markers Monoclonal Neoplasms Pericytes Protocols Randomized Research Schedule Survival Topic Trials Tumor administration analysis as blood dosage drug effects mortality supply therapeutic therapy use - R. Kumar, M. C. Crouthamel, D. H. Rominger, R. R. Gontarek, P. J. Tummino, R. A. Levin, and A. G. King. Br.J.Cancer 101(10):1717-1723 (2009)R. Kumar, M. C. Crouthamel, D. H. Rominger, R. R. Gontarek, P. J. Tummino, R. A. Levin, and A. G. King. Br.J.Cancer 101(10):1717-1723 (2009)3 years and 4 months agoby kanefendt1
- &
- 3
- 50
- Angiogenesis
- Benzenesulfonates
- Bone
- Cell
- Cells
- Concentration
- Diseases
- Endothelial
- Factor
- Growth
- Hematologic
- Hematopoietic
- Human
- Humans
- Indoles
- Inhibitors
- Inhibitory
- Kinase
- Line
- Marrow
- Myelopoiesis
- Phosphorylation
- Platelet-Derived
- Protein
- Proteins
- Proto-Oncogene
- Pyridines
- Pyrimidines
- Pyrroles
- Receptors
- Research
- Specificity
- Stem
- Substrate
- Sulfonamides
- Tumor
- Tyrosine
- Vascular
- antagonists
- c-kit
- chemically
- drug
- effects
- enzymology
- fms-Like
- induced
- inhibitors
- methods
- pharmacology
- protein
& 3 50 Angiogenesis Benzenesulfonates Bone Cell Cells Concentration Diseases Endothelial Factor Growth Hematologic Hematopoietic Human Humans Indoles Inhibitors Inhibitory Kinase Line Marrow Myelopoiesis Phosphorylation Platelet-Derived Protein Proteins Proto-Oncogene Pyridines Pyrimidines Pyrroles Receptors Research Specificity Stem Substrate Sulfonamides Tumor Tyrosine Vascular antagonists c-kit chemically drug effects enzymology fms-Like induced inhibitors methods pharmacology protein - R. K. Jain, D. G. Duda, C. G. Willett, D. V. Sahani, A. X. Zhu, J. S. Loeffler, T. T. Batchelor, and A. G. Sorensen. Nat.Rev.Clin.Oncol. 6(6):327-338 (2009)R. K. Jain, D. G. Duda, C. G. Willett, D. V. Sahani, A. X. Zhu, J. S. Loeffler, T. T. Batchelor, and A. G. Sorensen. Nat.Rev.Clin.Oncol. 6(6):327-338 (2009)3 years and 4 months agoby kanefendt1
- C. Sessa, A. Guibal, Conte G. Del, and C. Ruegg. Nat.Clin.Pract.Oncol. 5(7):378-391 (2008)C. Sessa, A. Guibal, Conte G. Del, and C. Ruegg. Nat.Clin.Pract.Oncol. 5(7):378-391 (2008)3 years and 4 months agoby kanefendt1